NCT07654140: A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension
- State
- Under way
- Phase
- Phase 2
- People
- 252 planned
- Started
- 9 Dec 2025
- Primary completion
- 1 Mar 2027
- Arms
- Low-dose group, Middle-dose group, High-dose group
- Results
- None posted
- 9 Dec 2025: Trial started
- 17 Jun 2026: Trial registered